(l)-2-benzyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline | 94086-06-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: (l)-2-benzyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline
• 英文别名: 2-benzyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline；2-benzyl-3,4-dihydro-1H-isoquinolin-7-ol
• CAS: 94086-06-3
• 化学式: C₁₆H₁₇NO
• 分子量: 239.317
• InChiKey: MHCFMNDJGYWJSN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (l)-2-benzyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline 在 盐酸 、 偶氮二甲酸二异丙酯 、 10% palladium hydroxide on charcoal 、 氢气 、 potassium carbonate 、 1-羟基苯并三唑 、 一水合肼 、 N,N-二异丙基乙胺 、 N,N'-二环己基碳二亚胺 、 三苯基膦 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 135.0 ℃ 、344.75 kPa 条件下， 反应 40.5h， 生成
  参考文献：
  名称：

  EP3747883

  摘要：

  公开号：
• 作为产物：
  描述：

  2-benzyl-7-methoxy-1,2,3,4-tetrahydroisoquinoline 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 生成 (l)-2-benzyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists

  摘要：

  SCH 58261 is a reported adenosine A(2A) receptor antagonist which is active in rat in vivo models of Parkinson's Disease upon ip administration. However, it has poor selectivity versus the A(1) receptor and does not demonstrate oral activity. Quinoline analogs have improved upon the selectivity and pharmacokinetics of SCH 58261, but were difficult to handle due to poor aqueous solubility. We report the design and synthesis of fused heterocyclic analogs of SCH 58261 with aqueous solubility as well as improved A(2A) receptor binding selectivity and pharmacokinetic properties. In particular, the tetrahydronaphthyridine 4s has excellent A(2A) receptor in vitro binding affinity and selectivity, is active orally in a rat in vivo model of Parkinson's Disease, and has aqueous solubility of 100 mu M at physiological pH. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.05.069

文献信息

• Monocyclic β-lactam compound for treating bacterial infection
  申请人：MEDSHINE DISCOVERY INC.

  公开号：US11459323B2

  公开（公告）日：2022-10-04

  Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated with bacterial infection. Specifically disclosed are the compounds as shown in formula (I′) and formula (II′), isomers thereof or pharmaceutically acceptable salts thereof.

  公开了一类新的单环β-内酰胺化合物、其异构体或其药学上可接受的盐、包含这些化合物的药物组合物，以及这些化合物在制备治疗与细菌感染有关的疾病的药物中的用途。具体公开了式(Ⅰ′)和式(Ⅱ′)所示的化合物、其异构体或其药学上可接受的盐。
• MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION
  申请人：MEDSHINE DISCOVERY INC.

  公开号：US20210115035A1

  公开（公告）日：2021-04-22

  Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated with bacterial infection. Specifically disclosed are the compounds as shown in formula (I′) and formula (II′), isomers thereof or pharmaceutically acceptable salts thereof.